Daily Stock Playbook: Buy/Sell Ideas Today - 12 March, 2024

The benchmark index underwent a subdued opening followed by a sustained descent across the trading day, ultimately ending with a notable 0.72% decline.

In contrast, the Nifty Midcap 100 index exhibited marginally better resilience but still closed marginally lower by 0.39%.

Several sectors demonstrated contrasting fortunes. Pharma and Healthcare emerged as steadfast performers, defying the overall market trend. However, Media and PSU Banks found themselves on the back foot, encountering significant hurdles that hindered their progress.

An analysis of the options market reveals a concentration of open interest in call options at the 22500 level and in put options at the 21800 level. Notably, a higher degree of call writing has been observed relative to put writing, reflecting a prevalent negative sentiment among traders.

The Volume Weighted Average Price (VWAP) suggests a potential trading range between 22220 and 22530 for the current session. The Max Pain level rests at 22400 spot, with a CE/PE Combined Residual Premium/Pain Value of 198.88 Crores.

In the cash market, Foreign Institutional Investors (FIIs) emerged as net buyers, contributing a significant 4212.76 crore to the market's total activity. On the domestic front, Domestic Institutional Investors (DIIs) also displayed a positive stance, recording net buying of 3238.39 crore.

Stocks to Buy Today:

1] BUY GODFRYPHLP at ₹3377.7 CMP for intraday timeframe.

2] BUY JSL at ₹644.35 CMP for intraday timeframe.

3] BUY CSBBANK at ₹348.25 CMP for intraday timeframe.

4] BUY KPIL at ₹1056.05 CMP for intraday timeframe.

Stocks to Short Today:

1] SELL ABCAPITAL at ₹184.5 CMP for intraday timeframe.

2] SELL RATNAMANI at ₹2700 CMP for intraday timeframe.

3] SELL CASTROLIND at ₹206.65 CMP for intraday timeframe.

4] SELL RVNL at ₹240.95 CMP for intraday timeframe.

Disclaimer: Remember, the market is a living beast, and even the most informed predictions can be devoured by unforeseen events. While this analysis is based on a thorough rule-based research, the ultimate decision to buy or sell rests with you. Do your own due diligence, consider your risk tolerance, and craft a strategy that aligns with your financial goals. Stratzy provides insights, not guarantees, and cannot be held responsible for any gains or losses incurred in your trading activities. Invest wisely, trade responsibly, and may the market gods favor you!